Xử lý sự chống đông máu và đảo ngược tác dụng

Reversal of antithrombotic agents. (mở cửa sổ mới)

Bauer KA.

Nguồn‎: Am J Hematol 2012;87 Suppl 1:S119-26.

Mã bài‎: PubMed 22460529

DOI‎: 10.1002/ajh.23165

https://www.ncbi.nlm.nih.gov/pubmed/22460529 (mở cửa sổ mới)

Hemodialysis for the treatment of dabigatran-associated bleeding: a case report and systematic review. (mở cửa sổ mới)

Chai-Adisaksopha C, Hillis C, Lim W, Boonyawat K, Moffat K, Crowther M

Nguồn‎: J Thromb Haemost 2015;13(10):1790-8.

Mã bài‎: PubMed 26270886

DOI‎: 10.1111/jth.13117

https://www.ncbi.nlm.nih.gov/pubmed/26270886 (mở cửa sổ mới)

Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. (mở cửa sổ mới)

Connolly SJ, Crowther M, Eikelboom JW, Gibson CM, Curnutte JT, Lawrence JH, Yue P, Bronson MD, Lu G, Conley PB, Verhamme P, Schmidt J, Middeldorp S, Cohen AT, Beyer-Westendorf J, Albaladejo P, Lopez-Sendon J, Demchuk AM, Pallin DJ, Concha M, Goodman S, Leeds J, Souza S, Siegal DM, Zotova E, Meeks B, Ahmad S, Nakamya J, Milling TJ Jr; ANNEXA-4 Investigators

Nguồn‎: N Engl J Med 2019;380(14):1326-35.

Mã bài‎: PubMed 30730782

DOI‎: 10.1056/NEJMoa1814051

https://www.ncbi.nlm.nih.gov/pubmed/30730782 (mở cửa sổ mới)

Andexanet alfa for acute major bleeding associated with factor Xa inhibitors. (mở cửa sổ mới)

Connolly SJ, Milling TJ Jr, Eikelboom JW, Gibson CM, Curnutte JT, Gold A, Bronson MD, Lu G, Conley PB, Verhamme P, Schmidt J, Middeldorp S, Cohen AT, Beyer-Westendorf J, Albaladejo P, Lopez-Sendon J, Goodman S, Leeds J, Wiens BL, Siegal DM, Zotova E, Meeks B, Nakamya J, Lim WT, Crowther M; ANNEXA-4 Investigators

Nguồn‎: N Engl J Med 2016;375(12):1131-41.

Mã bài‎: PubMed 27573206

DOI‎: 10.1056/NEJMoa1607887

https://www.ncbi.nlm.nih.gov/pubmed/27573206 (mở cửa sổ mới)

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. (mở cửa sổ mới)

Eerenberg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M

Nguồn‎: Circulation 2011;124(14):1573-9.

Mã bài‎: PubMed 21900088

DOI‎: 10.1161/CIRCULATIONAHA.111.029017

https://www.ncbi.nlm.nih.gov/pubmed/21900088 (mở cửa sổ mới)

Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. (mở cửa sổ mới)

Goldstein JN, Refaai MA, Milling TJ Jr, Lewis B, Goldberg-Alberts R, Hug BA, Sarode R.

Nguồn‎: Lancet 2015;385(9982):2077-87.

Mã bài‎: PubMed 25728933

DOI‎: 10.1016/S0140-6736(14)61685-8

https://www.ncbi.nlm.nih.gov/pubmed/25728933 (mở cửa sổ mới)

Anticoagulant and antiplatelet medications encountered in emergency surgery patients: a review of reversal strategies. (mở cửa sổ mới)

Gordon JL, Fabian TC, Lee MD, Dugdale M

Nguồn‎: J Trauma Acute Care Surg 2013;75(3):475-86.

Mã bài‎: PubMed 24089118

DOI‎: 10.1097/TA.0b013e3182a07391

https://www.ncbi.nlm.nih.gov/pubmed/24089118 (mở cửa sổ mới)

Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. (mở cửa sổ mới)

Kaatz S, Kouides PA, Garcia DA, Spyropolous AC, Crowther M, Douketis JD, Chan AK, James A, Moll S, Ortel TL, Van Cott EM, Ansell J.

Nguồn‎: Am J Hematol 2012;87 Suppl 1:S141-5.

Mã bài‎: PubMed 22473649

DOI‎: 10.1002/ajh.23202

https://www.ncbi.nlm.nih.gov/pubmed/22473649 (mở cửa sổ mới)

Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. (mở cửa sổ mới)

Levi M, Eerenberg E, Kamphuisen PW.

Nguồn‎: J Thromb Haemost 2011;9(9):1705-12.

Mã bài‎: PubMed 21729240

DOI‎: 10.1111/j.1538-7836.2011.04432.x

https://www.ncbi.nlm.nih.gov/pubmed/21729240 (mở cửa sổ mới)

Emergency reversal of warfarin anticoagulation. (mở cửa sổ mới)

Lin Y, Callum J.

Nguồn‎: CMAJ 2010;182(18):2004.

Mã bài‎: PubMed 21078740

DOI‎: 10.1503/cmaj.100983

https://www.ncbi.nlm.nih.gov/pubmed/21078740 (mở cửa sổ mới)

Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers. (mở cửa sổ mới)

Marlu R, Hodaj E, Paris A, Albaladejo P, Cracowski JL, Pernod G.

Nguồn‎: Thromb Haemost 2012;108(2):217-24.

Mã bài‎: PubMed 22627883

DOI‎: 10.1160/TH12-03-0179

https://www.ncbi.nlm.nih.gov/pubmed/22627883 (mở cửa sổ mới)

Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial. (mở cửa sổ mới)

Pabinger I, Brenner B, Kalina U, Knaub S, Nagy A, Ostermann H; Beriplex P/N Anticoagulation Reversal Study Group.

Nguồn‎: J Thromb Haemost 2008;6(4):622-31.

Mã bài‎: PubMed 18208533

DOI‎: 10.1111/j.1538-7836.2008.02904.x

https://www.ncbi.nlm.nih.gov/pubmed/18208533 (mở cửa sổ mới)

Management of direct factor Xa inhibitor-related major bleeding with prothrombin complex concentrate: a meta-analysis. (mở cửa sổ mới)

Piran S, Khatib R, Schulman S, Majeed A, Holbrook A, Witt DM, Wiercioch W, Schünemann HJ, Nieuwlaat R

Nguồn‎: Blood Adv 2019;3(2):158-67.

Mã bài‎: PubMed 30658963

DOI‎: 10.1182/bloodadvances.2018024133

https://www.ncbi.nlm.nih.gov/pubmed/30658963 (mở cửa sổ mới)

Idarucizumab for dabigatran reversal. (mở cửa sổ mới)

Pollack CV Jr, Reilly PA, Eikelboom J, Glund S, Verhamme P, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kamphuisen PW, Kreuzer J, Levy JH, Sellke FW, Stangier J, Steiner T, Wang B, Kam CW, Weitz JI.

Nguồn‎: N Engl J Med 2015;373(6):511-20.

Mã bài‎: PubMed 26095746

DOI‎: 10.1056/NEJMoa1502000

https://www.ncbi.nlm.nih.gov/pubmed/26095746 (mở cửa sổ mới)

Idarucizumab for dabigatran reversal - full cohort analysis. (mở cửa sổ mới)

Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kam CW, Kamphuisen PW, Kreuzer J, Levy JH, Royle G, Sellke FW, Stangier J, Steiner T, Verhamme P, Wang B, Young L, Weitz JI

Nguồn‎: N Engl J Med 2017;377(5):431-41.

Mã bài‎: PubMed 28693366

DOI‎: 10.1056/NEJMoa1707278

https://www.ncbi.nlm.nih.gov/pubmed/28693366 (mở cửa sổ mới)

Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin. (mở cửa sổ mới)

Reiter RA, Mayr F, Blazicek H, Galehr E, Jilma-Stohlawetz P, Domanovits H, Jilma B

Nguồn‎: Blood 2003;102(13):4594-9.

Mã bài‎: PubMed 12920042

DOI‎: 10.1182/blood-2002-11-3566

https://www.ncbi.nlm.nih.gov/pubmed/12920042 (mở cửa sổ mới)

Role of agents for reversing the effects of target-specific oral anticoagulants. (mở cửa sổ mới)

Riley TR, Gauthier-Lewis ML, Sanchez CK, Douglas JS

Nguồn‎: Am J Health Syst Pharm 2017;74(2):54-61.

Mã bài‎: PubMed 27895055

DOI‎: 10.2146/ajhp150810

https://www.ncbi.nlm.nih.gov/pubmed/27895055 (mở cửa sổ mới)

Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. (mở cửa sổ mới)

Skolnick BE, Shenouda M, Khutoryansky NM, Pusateri AE, Gabriel D, Carr ME.

Nguồn‎: Anesth Analg 2011;113(4):703-10.

Mã bài‎: PubMed 21890888

DOI‎: 10.1213/ANE.0b013e318228c690

https://www.ncbi.nlm.nih.gov/pubmed/21890888 (mở cửa sổ mới)

2017 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. (mở cửa sổ mới)

Tomaselli GF, Mahaffey KW, Cuker A, Dobesh PP, Doherty JU, Eikelboom JW, Florido R, Hucker W, Mehran R, Messé SR, Pollack CV Jr, Rodriguez F, Sarode R, Siegal D, Wiggins BS

Nguồn‎: J Am Coll Cardiol 2017;70(24):3042-67.

Mã bài‎: PubMed 29203195

DOI‎: 10.1016/j.jacc.2017.09.1085

https://www.ncbi.nlm.nih.gov/pubmed/29203195 (mở cửa sổ mới)

Rapid warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate. (mở cửa sổ mới)

Woo CH, Patel N, Conell C, Rao VA, Faigeles BS, Patel MC, Pombra J, Akins PT, Axelrod YK, Ge IY, Sheridan WF, Flint AC.

Nguồn‎: World Neurosurg 2014;81(1):110-5.

Mã bài‎: PubMed 23220122

DOI‎: 10.1016/j.wneu.2012.12.002

https://www.ncbi.nlm.nih.gov/pubmed/23220122 (mở cửa sổ mới)

Reversal of warfarin-induced hemorrhage in the emergency department. (mở cửa sổ mới)

Zareh M, Davis A, Henderson S.

Nguồn‎: West J Emerg Med 2011;12(4):386-92.

Mã bài‎: PubMed 22224125

DOI‎: 10.5811/westjem.2011.3.2051

https://www.ncbi.nlm.nih.gov/pubmed/22224125 (mở cửa sổ mới)

HỒI SỨC TÍCH CỰC

Xử lý sự chống đông máu và đảo ngược tác dụng

Việt

Xử lý sự chống đông máu và đảo ngược tác dụng

https://assetsnffrgf-a.akamaihd.net/assets/ct/d8f8c0370e/images/syn_placeholder_sqr.png

Xử lý sự chống đông máu và đảo ngược tác dụng

Reversal of antithrombotic agents. (mở cửa sổ mới)

Hemodialysis for the treatment of dabigatran-associated bleeding: a case report and systematic review. (mở cửa sổ mới)

Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. (mở cửa sổ mới)

Andexanet alfa for acute major bleeding associated with factor Xa inhibitors. (mở cửa sổ mới)

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. (mở cửa sổ mới)

Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. (mở cửa sổ mới)

Anticoagulant and antiplatelet medications encountered in emergency surgery patients: a review of reversal strategies. (mở cửa sổ mới)

Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. (mở cửa sổ mới)

Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. (mở cửa sổ mới)

Emergency reversal of warfarin anticoagulation. (mở cửa sổ mới)

Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers. (mở cửa sổ mới)

Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial. (mở cửa sổ mới)

Management of direct factor Xa inhibitor-related major bleeding with prothrombin complex concentrate: a meta-analysis. (mở cửa sổ mới)

Idarucizumab for dabigatran reversal. (mở cửa sổ mới)

Idarucizumab for dabigatran reversal - full cohort analysis. (mở cửa sổ mới)

Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin. (mở cửa sổ mới)

Role of agents for reversing the effects of target-specific oral anticoagulants. (mở cửa sổ mới)

Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. (mở cửa sổ mới)

2017 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. (mở cửa sổ mới)

Rapid warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate. (mở cửa sổ mới)

Reversal of warfarin-induced hemorrhage in the emergency department. (mở cửa sổ mới)

Liên hệ với người đại diện Ủy ban Liên lạc Bệnh viện

Các gói thông tin y khoa

Video

Xử lý sự chống đông máu và đảo ngược tác dụng

Chọn ngôn ngữ

Chia sẻ